Press release
Radiopharmaceutical CDMO/CMO Services Market Top Companies Study - PharmaLogic, Eckert & Ziegler, AtomVie, Eczacıbaşı-Monrol.
Radiopharmaceutical CDMO/CMO Services Market
Global Radiopharmaceutical CDMO/CMO Services Market 2025-2034 full Research Repot latest version is now available.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2472
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global radiopharmaceutical CDMO/CMO services market are:
• Growing prevalence of cancer
• Growing interest in personalized treatment
• Technological advancements
The following are the primary obstacles to the radiopharmaceutical CDMO/CMO services market's expansion:
• High cost
• Inadequate infrastructure
• Shortages of skilled workers
Future expansion opportunities for the global radiopharmaceutical CDMO/CMO services market include:
• Growing use of nuclear therapy in underdeveloped nations
• Increasing investments in research and development
• Increased partnership with pharmaceutical industries
Key Industry Insights & Findings from the report:
• The market is growing rapidly due to supportive government initiatives and technological advancements.
• The market for radiopharmaceutical CDMO/CMO services is driven by the increasing incidence of cancer and pharmaceutical firms outsourcing manufacturing to save costs and comply with regulations.
• North America dominated the market and accounted for a revenue share of global revenue in 2023.
• High costs and lack of infrastructure are major issues impeding industry expansion.
Market Analysis:
The radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services market is experiencing robust growth, primarily driven by the increasing incidence of cardiovascular diseases and cancer, along with a rising demand for nuclear-based therapies and advancements in radiopharmaceutical technologies. Additionally, strong governmental support, elevated research and development expenditures, and the continued evolution of medical imaging applications are significantly contributing to market expansion. The growing emphasis on personalized medicine and the ongoing requirement for tailored therapeutic solutions further support the increasing adoption of radiopharmaceutical contract development and manufacturing services.
List of Prominent Players in the Radiopharmaceutical CDMO/CMO Services Market:
• Minerva Imaging
• Evergreen Theragnostics, Inc.
• NMR (NorthStar Medical Radioisotopes
• PharmaLogic
• Eckert & Ziegler
• AtomVie
• Eczacıbaşı-Monrol
• Cardinal Health
• Nucleus RadioPharma
• Seibersdorf Labor GmbH
• Global Medical Solutions
• SOFIE
• SpectronRx
• Agilera Pharma AS
• Siemens Healthineers
• Grupo RPH
• Almac Group
• Medi-Radiopharma
• Itm Radiopharma
• Nihon Medi-Physics Co., Ltd.
• IONETIX Corporation
• GBI
• DuchemBio, Co., Ltd
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Recent Developments:
• In February 2024, the clinical-stage radiopharmaceutical company Evergreen Theragnostics, Inc. announced that it has partnered and licensed with the Medical University of Innsbruck, a preeminent European research institution, to promote the development of innovative radiopharmaceuticals.
• In February 2025, Lantheus Holdings, Inc. announced a definitive agreement to acquire Evergreen Theragnostics, Inc. ("Evergreen") in an all-cash transaction that includes a $250 million upfront payment and up to an additional $752.5 million in potential milestone payments. The company is dedicated to helping clinicians Find, Fight, and Follow disease to improve patient outcomes.
• In October 2024, Atley Solutions delivered and installed the first commercial unit at Minerva Imaging's facilities in Denmark, following the regulatory approval and launch of the world's first commercial module for making Astatine-211 (At-211) radiopharmaceuticals. With the release of the Atley C100, Atley Solutions has achieved a major technical and business milestone, solidifying its position as a world leader in commercial products and services for At-211 radiopharmaceuticals.
Radiopharmaceutical CDMO/CMO Services Market Dynamics:
Market Drivers: Technological Advancements
The expansion of the radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services market is largely attributed to ongoing technological advancements. Innovations in artificial intelligence (AI)-driven imaging, automated radiopharmaceutical production, and the evolution of nuclear medicine technologies are significantly enhancing the precision and efficacy of treatments. Progress in drug formulation, the introduction of novel isotopes, and the development of personalized radiotherapies are further improving therapeutic outcomes. Moreover, advancements in quality assurance, regulatory compliance, and radiopharmaceutical synthesis are streamlining production processes, thereby supporting continued market growth.
Challenges: High Operational Costs
The growth of the radiopharmaceutical CDMO/CMO services market is hindered by substantial operational costs. These include high expenses related to raw materials, complex and highly regulated production processes, and specialized logistics due to the short half-life of radioisotopes. The requirement for purpose-built facilities, skilled personnel, radiation safety measures, and stringent quality control systems further increases the financial burden. These factors collectively limit the scalability and accessibility of services, posing challenges to broader market expansion.
Regional Outlook: North America
North America is anticipated to lead the radiopharmaceutical CDMO/CMO services market, demonstrating the highest compound annual growth rate (CAGR) over the forecast period. This growth is driven by rising demand for nuclear medicine, increasing prevalence of cancer and cardiovascular diseases, and significant investment in research and development within the radiopharmaceutical sector. The region benefits from a well-established healthcare infrastructure, supportive regulatory frameworks, and substantial governmental backing. Furthermore, the presence of major pharmaceutical firms, specialized CDMOs, and continuous innovations in targeted radiotherapies are expected to sustain and accelerate market growth in North America.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2472
Segmentation of Radiopharmaceutical CDMO/CMO Services Market-
By Application-
• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals
By Type of Radioisotope-
• Technetium-99m
• Fluorine-18
• Leutetium-177
• Gallium-68
• Actinium-225
• Others
By Source of Manufacturing-
• Nuclear Reactors
• Cyclotrons
By Scale of Operation-
• Preclinical
• Clinical
• Commercial
By Therapeutic Area-
• Cardiovascular Disorders
• Neurological Disorders
• Oncological Disorders
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/radiopharmaceutical-cdmocmo-services-market/2472
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceutical CDMO/CMO Services Market Top Companies Study - PharmaLogic, Eckert & Ziegler, AtomVie, Eczacıbaşı-Monrol. here
News-ID: 4077331 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Rare Earth Magnet Market Size, Share and Trends Analysis Report 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rare Earth Magnet Market- (By Type (Neodymium-Iron-Boron Magnet (NdFeB), Samarium Cobalt Magnet (SmCo)), Product (Countersunk Magnets, Circular Disc Magnets, Hook & Eyebolt Magnets, Cylindrical Rod Magnets, Circular Ring Magnets, Rectangular, Self-Adhesive, Pot & Clamping Magnets), Application (Automotive Industry, Food & Drink Processing, Aerospace Industry, Renewable Energy, Consumer Electronics, Deep Sea Exploration, Others)), Trends, Industry Competition…
Partially Hydrolyzed Polyacrylamide (PHPA) Market Survey Detailed Analysis and F …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Partially Hydrolyzed Polyacrylamide (PHPA) Market- (By Type (Anionic, Cationic, Non-ionic, Others), By Function (Viscosifying Agent, Shale bore-hole Stabilizer, Excapsulator, Flocculation Agent, Others), By Application (Drilling Fluids, Water Treatment Additive, Soil Stabilization, Paper Manufacturing, Others), By End-Use (Oil & Gas, Waste Water Treatment, Mining, Agriculture, Paper, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
Modular Construction Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Modular Construction Market Size, Share & Trends Analysis Report By Type (permanent, relocatable), Module (Four-Sided Modules, Open-Sided Modules, Partially Open Sided Modules, Mixed Modules & Floor Cassettes, Modules Supported By a Primary Structure), Material (steel, wood, concrete), End-user (residential, office, education, retail & commercial, hospitality, healthcare), Region, Market Outlook And Industry Analysis 2034"
The global modular…
Metal Recycling Market Current Scenario with Future Trends Analysis to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Metal Recycling Market- (By Type (Ferrous, Non-Ferrous Metals), By Equipment (Shredders, Shears, Granulating Machines, Briquetting Machines), By End-User (Building and Construction, Packaging, Automotive, Shipbuilding, Electronics Equipment, Electrical Equipment)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Metal Recycling Market Size is valued at 549.4…
More Releases for CDMO
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract…
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Inhalation CDMO Market Size During the Forecast Period?
In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024…
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size?
The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of…
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest…
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage
A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications.
The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for…
